HMB-002

N/A

Report date: 2025/02/19 16:44:06

Base Information

Drug NameHMB-002
Drug Alias NameHMB-002HMB-VWF
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionVon willebrand factor modulatorsCoagulation factor VIII modulators
TargetsVon willebrand factorCoagulation factor VIII
Therapy Area/Indicationsvon Willebrand Disease, Type 2von Willebrand Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHemab APS
China Registration ClassN/A

Develop Information

Active CompaniesHemab APS
Inactive CompaniesN/A
Active Indicationsvon Willebrand Disease, Type 2von Willebrand Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A